High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score.
Aged
Asymptomatic Diseases
Computed Tomography Angiography
Coronary Angiography
Coronary Artery Disease
/ diagnostic imaging
Cross-Sectional Studies
Denmark
/ epidemiology
Diabetes Mellitus, Type 2
/ diagnosis
Female
Humans
Male
Middle Aged
Multidetector Computed Tomography
Plaque, Atherosclerotic
Predictive Value of Tests
Prevalence
Risk Assessment
Risk Factors
Vascular Calcification
/ diagnostic imaging
Asymptomatic coronary artery disease
Atherosclerosis
Coronary artery calcium score
Coronary computed tomography angiography
High-risk plaque
Type 2 diabetes
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
09 08 2021
09 08 2021
Historique:
received:
29
04
2021
accepted:
17
07
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
4
1
2022
Statut:
epublish
Résumé
High-risk coronary artery plaque (HRP) is associated with increased risk of acute coronary syndrome. We aimed to investigate the prevalence of HRP in asymptomatic patients with type 2 diabetes (T2D), and its relation to patient characteristics including cardiovascular risk factors, diabetes profile, and coronary artery calcium score (CACS). Asymptomatic patients with T2D and no previous coronary artery disease (CAD) were studied using coronary computed tomography angiography (CCTA) in this descriptive study. Plaques with two or more high-risk features (HRP) defined by low attenuation, positive remodeling, spotty calcification, and napkin-ring sign were considered HRP. In addition, total atheroma volume (TAV), proportions of dense calcium, fibrous, fibrous-fatty and necrotic core volumes were assessed. The CACS was obtained from non-enhanced images by the Agatston method. Cardiovascular and diabetic profiles were assessed in all patients. In 230 patients CCTA was diagnostic and 161 HRP were detected in 86 patients (37%). Male gender (OR 4.19, 95% CI 1.99-8.87; p < 0.01), tobacco exposure in pack years (OR 1.02, 95% CI 1.00-1.03; p = 0.03), and glycated hemoglobin (HbA1c) (OR 1.04, 95% CI 1.02-1.07; p < 0.01) were independent predictors of HRP. No relationship was found to other risk factors. HRP was not associated with increased CACS, and 13 (23%) patients with zero CACS had at least one HRP. A high prevalence of HRP was detected in this population of asymptomatic T2D. The presence of HRP was associated with a particular patient profile, but was not ruled out by the absence of coronary artery calcium. CCTA provides important information on plaque morphology, which may be used to risk stratify this high-risk population. Trial registration This trial was retrospectively registered at clinical trials.gov January 11, 2017 trial identifier NCT03016910.
Sections du résumé
BACKGROUND
High-risk coronary artery plaque (HRP) is associated with increased risk of acute coronary syndrome. We aimed to investigate the prevalence of HRP in asymptomatic patients with type 2 diabetes (T2D), and its relation to patient characteristics including cardiovascular risk factors, diabetes profile, and coronary artery calcium score (CACS).
METHODS
Asymptomatic patients with T2D and no previous coronary artery disease (CAD) were studied using coronary computed tomography angiography (CCTA) in this descriptive study. Plaques with two or more high-risk features (HRP) defined by low attenuation, positive remodeling, spotty calcification, and napkin-ring sign were considered HRP. In addition, total atheroma volume (TAV), proportions of dense calcium, fibrous, fibrous-fatty and necrotic core volumes were assessed. The CACS was obtained from non-enhanced images by the Agatston method. Cardiovascular and diabetic profiles were assessed in all patients.
RESULTS
In 230 patients CCTA was diagnostic and 161 HRP were detected in 86 patients (37%). Male gender (OR 4.19, 95% CI 1.99-8.87; p < 0.01), tobacco exposure in pack years (OR 1.02, 95% CI 1.00-1.03; p = 0.03), and glycated hemoglobin (HbA1c) (OR 1.04, 95% CI 1.02-1.07; p < 0.01) were independent predictors of HRP. No relationship was found to other risk factors. HRP was not associated with increased CACS, and 13 (23%) patients with zero CACS had at least one HRP.
CONCLUSION
A high prevalence of HRP was detected in this population of asymptomatic T2D. The presence of HRP was associated with a particular patient profile, but was not ruled out by the absence of coronary artery calcium. CCTA provides important information on plaque morphology, which may be used to risk stratify this high-risk population. Trial registration This trial was retrospectively registered at clinical trials.gov January 11, 2017 trial identifier NCT03016910.
Identifiants
pubmed: 34372839
doi: 10.1186/s12933-021-01350-2
pii: 10.1186/s12933-021-01350-2
pmc: PMC8353743
doi:
Banques de données
ClinicalTrials.gov
['NCT03016910']
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
164Informations de copyright
© 2021. The Author(s).
Références
Am J Cardiol. 2010 Jan 1;105(1):48-53
pubmed: 20102889
Lancet. 2006 Jul 1;368(9529):29-36
pubmed: 16815377
Heart. 1999 Sep;82(3):269-72
pubmed: 10455073
J Invasive Cardiol. 2015 Aug;27(8):354-8
pubmed: 25999135
Am J Cardiol. 2016 May 1;117(9):1444-8
pubmed: 26969416
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 2):1353-1363
pubmed: 29778864
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1266-71
pubmed: 15142859
Atherosclerosis. 2015 Aug;241(2):579-87
pubmed: 26115069
Eur Heart J. 2006 Mar;27(6):713-21
pubmed: 16497686
Diabetes Care. 2014;37(3):830-8
pubmed: 24178997
Cardiovasc Diabetol. 2017 Dec 1;16(1):152
pubmed: 29195505
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Am J Cardiol. 2014 Sep 1;114(5):674-80
pubmed: 25048344
Int J Cardiovasc Imaging. 2011 Apr;27(4):593-600
pubmed: 20820922
Atherosclerosis. 2014 Oct;236(2):411-7
pubmed: 25150939
Int J Cardiovasc Imaging. 2013 Jun;29(5):1177-90
pubmed: 23417447
Coron Artery Dis. 2015 Jan;26(1):60-5
pubmed: 25171387
Int Heart J. 2012;53(1):23-8
pubmed: 22398672
Eur Heart J. 2013 Mar;34(10):719-28
pubmed: 23242196
Am J Cardiol. 2014 Mar 1;113(5):765-71
pubmed: 24528613
Circulation. 2008 Apr 15;117(15):1945-54
pubmed: 18378618
Diabetes Obes Metab. 2015 Mar;17(3):219-30
pubmed: 25160598
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
J Am Coll Cardiol. 2009 Jun 30;54(1):49-57
pubmed: 19555840
N Engl J Med. 1998 Jul 23;339(4):229-34
pubmed: 9673301
JACC Cardiovasc Imaging. 2018 Oct;11(10):1461-1471
pubmed: 29778853
Eur Heart J Cardiovasc Imaging. 2013 Nov;14(11):1099-105
pubmed: 23671211
JACC Cardiovasc Imaging. 2012 Apr;5(4):358-66
pubmed: 22498324
Eur Heart J. 2013 Nov;34(41):3182-90
pubmed: 23886915
Clin Radiol. 2013 Oct;68(10):1054-8
pubmed: 23809270
J Am Coll Cardiol. 2019 Sep 24;74(12):1608-1617
pubmed: 31537271
Eur Heart J. 2020 Jan 14;41(3):383-391
pubmed: 31504405
J Cardiovasc Comput Tomogr. 2015 Mar-Apr;9(2):e3
pubmed: 25708015
J Am Coll Cardiol. 2010 May 25;55(21):2399-407
pubmed: 20488313
Circ Cardiovasc Imaging. 2018 Jan;11(1):e006973
pubmed: 29305348
J Am Coll Cardiol. 2015 Apr 7;65(13):1273-1282
pubmed: 25835438
JAMA. 2014 Dec 3;312(21):2234-43
pubmed: 25402757
Atherosclerosis. 2014 Feb;232(2):298-304
pubmed: 24468142
N Engl J Med. 1997 May 1;336(18):1276-82
pubmed: 9113930
N Engl J Med. 1987 May 28;316(22):1371-5
pubmed: 3574413
J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301
pubmed: 33069847
Am J Cardiol. 2017 May 15;119(10):1566-1571
pubmed: 28343599
JACC Cardiovasc Interv. 2012 Nov;5(11):1150-8
pubmed: 23174639
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
Circulation. 2000 Feb 15;101(6):598-603
pubmed: 10673250
Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1170-1178
pubmed: 27679600
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):772-779
pubmed: 27502292
Circulation. 1996 Apr 1;93(7):1354-63
pubmed: 8641024
J Cardiovasc Comput Tomogr. 2013 May-Jun;7(3):192-9
pubmed: 23849492
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
Cardiovasc Diabetol. 2012 Jul 25;11:87
pubmed: 22831708